Literature DB >> 30009812

Evaluation of different classes of histamine H1 and H2 receptor antagonist effects on neuropathic nociceptive behavior following tibial nerve transection in rats.

Emad Khalilzadeh1, Farzin Azarpey2, Reza Hazrati3, Gholamreza Vafaei Saiah2.   

Abstract

It seems that histamine release in the site of neuronal injury could contribute to the neuropathic pain mechanism. In the present study, we investigated the anti-allodynic effects of chronic administration of different classes of histamine H1 and H2 receptor antagonists on neuropathic nociceptive behavior following tibial nerve transection (TNT) in rats. Peripheral neuropathy was induced by TNT surgery. We performed acetone tests (AT) to record cold allodynia, Von Frey tests (VFT) to measure mechanical allodynia, double plate test (DPT) to evaluate thermal place preference/avoidance and open field test (OFT) for evaluation of animal activity. TNT rats showed a significant mechanical and cold allodynia compared to the sham group. Chlorpheniramine (5 and 15 mg/kg, i.p) significantly attenuated cold allodynia and prevented cold plate avoidance behavior and at the dose of 15 mg/kg remarkably decreased mechanical allodynia. Fexofenadine (10 and 30 mg/kg, p.o) significantly attenuated the mechanical allodynia and prevented cold plate avoidance. Ranitidine (5 and 15 mg/kg, i.p) significantly prevented cold plate avoidance behavior and at the dose of 15 mg/kg notably improved mechanical and cold allodynia. Famotidine (1 and 3 mg/kg, p.o) was ineffective on all nociceptive tests. Gabapantin (100 mg/kg, p.o) significantly improved all types of nociceptive behaviors. These results indicate that both blood brain barrier penetrating (chlorpheniramine) and poorly penetrating (fexofenadine) histamine H1 receptor antagonists could improve the neuropathic pain sign, but only the blood brain barrier penetrating histamine H2 receptor antagonist (ranitidine) could produce anti-allodynic effects in the TNT model of neuropathic pain in rats.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Allodynia; Chlorpheniramine maleate (PubChem CID: 8231); Double plate test; Gabapantin; Histamine; Ketamine hydrochloride (PubChem CID: 15851); Neuropathic pain; Rats; carboxymethylcellulose (PubChem CID: 24748); famotidine hydrochloride (PubChem CID: 56841564); fexofenadine hydrochloride (PubChem CID: 63002); gabapentin (PubChem CID: 3446); ranitidine hydrochloride (PubChem CID: 3033332); xylazine hydrochloride (PubChem CID: 68554)

Mesh:

Substances:

Year:  2018        PMID: 30009812     DOI: 10.1016/j.ejphar.2018.07.011

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

Review 1.  Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review.

Authors:  Chang-Yu Hsieh; Tsen-Fang Tsai
Journal:  Dermatol Ther (Heidelb)       Date:  2021-04-12

2.  Dendritic cells in tumor microenvironment promoted the neuropathic pain via paracrine inflammatory and growth factors.

Authors:  Zhun Wang; Kai Song; Wenxin Zhao; Zhongmin Zhao
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

3.  Preventive action of benztropine on platinum-induced peripheral neuropathies and tumor growth.

Authors:  Olivier Cerles; Tânia Cristina Gonçalves; Sandrine Chouzenoux; Evelyne Benoit; Alain Schmitt; Nathaniel Edward Bennett Saidu; Niloufar Kavian; Christiane Chéreau; Camille Gobeaux; Bernard Weill; Romain Coriat; Carole Nicco; Frédéric Batteux
Journal:  Acta Neuropathol Commun       Date:  2019-01-18       Impact factor: 7.801

Review 4.  Histamine, histamine receptors, and neuropathic pain relief.

Authors:  Ilona Obara; Vsevolod Telezhkin; Ibrahim Alrashdi; Paul L Chazot
Journal:  Br J Pharmacol       Date:  2019-06-07       Impact factor: 8.739

5.  CNS-Sparing Histamine H3 Receptor Antagonist as a Candidate to Prevent the Diabetes-Associated Gastrointestinal Symptoms.

Authors:  Arianna Carolina Rosa; Patrizia Nardini; Silvia Sgambellone; Maura Gurrieri; Simona Federica Spampinato; Alfonso Dell'Accio; Paul L Chazot; Ilona Obara; Wai L Liu; Alessandro Pini
Journal:  Biomolecules       Date:  2022-01-22

Review 6.  Mediators of Neuropathic Pain; Focus on Spinal Microglia, CSF-1, BDNF, CCL21, TNF-α, Wnt Ligands, and Interleukin 1β.

Authors:  Paul A Boakye; Shao-Jun Tang; Peter A Smith
Journal:  Front Pain Res (Lausanne)       Date:  2021-08-25

7.  Votucalis, a Novel Centrally Sparing Histamine-Binding Protein, Attenuates Histaminergic Itch and Neuropathic Pain in Mice.

Authors:  Ibrahim Alrashdi; Amal Alsubaiyel; Michele Chan; Emma E Battell; Abdel Ennaceur; Miles A Nunn; Wayne Weston-Davies; Paul L Chazot; Ilona Obara
Journal:  Front Pharmacol       Date:  2022-03-08       Impact factor: 5.810

8.  Ventrolateral periaqueductal gray exogenous and endogenous histamine attenuates sciatic nerve chronic constriction injury-induced neuropathic pain through opioid receptors.

Authors:  Sara Salimi; Esmaeal Tamaddonfard; Farhad Soltanalinejad-Taghiabad
Journal:  Vet Res Forum       Date:  2021-12-15       Impact factor: 0.950

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.